Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC Matthews, AL Chue, D Wyllie, A Barnett, T Isinkaye… - Journal of Infection, 2014 - Elsevier
Objective Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20–60 mg/L for patients with severe infection. A …
被引用次数：50 相关文章

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC Matthews, AL Chue, D Wyllie… - Journal of …, 2014 - researchportal.ukhsa.gov.uk
Objective: Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60mg/L for patients with severe infection. A …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.

P Matthews, A Chue, D Wyllie, A Barnett… - Journal of …, 2014 - ora.ox.ac.uk
OBJECTIVE: Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60 mg/L for patients with severe infection. A …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.

PC Matthews, AL Chue, D Wyllie, A Barnett… - The Journal of …, 2013 - europepmc.org
Objective Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60 mg/L for patients with severe infection. A …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC Matthews, AL Chue, D Wyllie… - The Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Objective Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60 mg/L for patients with severe infection. A …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC Matthews, AL Chue, D Wyllie, A Barnett… - Journal of …, 2014 - journalofinfection.com
Objective Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20–60 mg/L for patients with severe infection. A …

[引用][C] Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC MATTHEWS, AL CHUE, D WYLLIE… - The Journal of …, 2014 - pascal-francis.inist.fr
Increased teicoplanin doses are associated with improved serum levels but not drug toxicity
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

PC Matthews, AL Chue, D Wyllie, A Barnett… - Journal of Infection, 2014 - infona.pl
Teicoplanin is widely used for the treatment of severe gram-positive infection, aiming to
achieve trough serum levels of 20–60 mg/L for patients with severe infection. A standard 400 …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.

PC Matthews, AL Chue, D Wyllie, A Barnett, T Isinkaye… - 2014 - cabidigitallibrary.org
Objective: Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60 mg/L for patients with severe infection. A …

Increased teicoplanin doses are associated with improved serum levels but not drug toxicity

P Matthews, A Chue, D Wyllie, A Barnett… - Journal of …, 2014 - ora.ox.ac.uk
Objective: Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20-60mg/L for patients with severe infection. A …